Bhisitkul R - Search Results

Year	Number of Results
1984	1
1987	1
1990	1
1991	1
1996	1
1997	1
1999	1
2000	6
2001	1
2002	1
2003	2
2004	4
2005	4
2006	2
2007	2
2008	3
2009	1
2010	4
2011	5
2012	5
2013	8
2014	3
2015	4
2016	6
2017	2
2018	2
2019	4
2020	1
2021	1
2022	1
2023	3
2024	3

1

Heterogeneity in disease activity, frequency of treatments, and visual outcomes among patients with retinal vein occlusion: relationship between injection need and vision with as-needed ranibizumab.

Bhisitkul RB, Campochiaro PA, Blotner S, Quezada-Ruiz C, Liu M, Haskova Z. Bhisitkul RB, et al. Br J Ophthalmol. 2024 Jan 30:bjo-2022-323120. doi: 10.1136/bjo-2022-323120. Online ahead of print. Br J Ophthalmol. 2024. PMID: 38290802 Free article.

2

Injectable Devices for Delivery of Liquid or Solid Protein Formulations.

Bernards DA, Ma CJ, Zhang Y, Rodriguez TM, Dickson J, Kharbikar BN, Bhisitkul RB, Desai TA. Bernards DA, et al. Among authors: bhisitkul rb. ACS Mater Au. 2023 Mar 13;3(3):255-264. doi: 10.1021/acsmaterialsau.3c00004. eCollection 2023 May 10. ACS Mater Au. 2023. PMID: 38089136 Free PMC article.

3

Safety and tolerability of intravitreal umedaptanib pegol (anti-FGF2) for neovascular age-related macular degeneration (nAMD): a phase 1, open-label study.

Pereira DS, Akita K, Bhisitkul RB, Nishihata T, Ali Y, Nakamura E, Nakamura Y. Pereira DS, et al. Among authors: bhisitkul rb. Eye (Lond). 2024 Apr;38(6):1149-1154. doi: 10.1038/s41433-023-02849-6. Epub 2023 Dec 1. Eye (Lond). 2024. PMID: 38040965 Free PMC article. Clinical Trial.

4

Clinical proof of concept for anti-FGF2 therapy in exudative age-related macular degeneration (nAMD): phase 2 trials in treatment-naïve and anti-VEGF pretreated patients.

Pereira DS, Maturi RK, Akita K, Mahesh V, Bhisitkul RB, Nishihata T, Sakota E, Ali Y, Nakamura E, Bezwada P, Nakamura Y. Pereira DS, et al. Among authors: bhisitkul rb. Eye (Lond). 2024 Apr;38(6):1140-1148. doi: 10.1038/s41433-023-02848-7. Epub 2023 Nov 30. Eye (Lond). 2024. PMID: 38036609 Free PMC article. Clinical Trial.

5

Macular Atrophy Incidence, Progression, and Visual Acuity Effects in 5-Year Treatment of Neovascular Age-Related Macular Degeneration.

Richardson QR, Zhang Y, Deiner MS, Wang ST, Bhisitkul JM, Arnold BF, Bhisitkul RB. Richardson QR, et al. Among authors: bhisitkul rb. Ophthalmic Surg Lasers Imaging Retina. 2022 Oct;53(10):546-552. doi: 10.3928/23258160-20220914-01. Epub 2022 Oct 1. Ophthalmic Surg Lasers Imaging Retina. 2022. PMID: 36239676

6

Rhegmatogenous retinal detachment masquerading as exudative panuveitis with intense anterior chamber inflammatory reaction.

Joye AS, Bhisitkul RB, Pereira DDS, Gonzales JA. Joye AS, et al. Among authors: bhisitkul rb. Am J Ophthalmol Case Rep. 2020 Feb 15;18:100618. doi: 10.1016/j.ajoc.2020.100618. eCollection 2020 Jun. Am J Ophthalmol Case Rep. 2020. PMID: 32154433 Free PMC article.

7

Glass intraocular foreign body removal with a nitinol stone basket.

Francis AW, Wu F, Zhu I, de Souza Pereira D, Bhisitkul RB. Francis AW, et al. Among authors: bhisitkul rb. Am J Ophthalmol Case Rep. 2019 Aug 10;16:100541. doi: 10.1016/j.ajoc.2019.100541. eCollection 2019 Dec. Am J Ophthalmol Case Rep. 2019. PMID: 31517137 Free PMC article.

8

Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal Disease.

Matsuda Y, Nonaka Y, Futakawa S, Imai H, Akita K, Nishihata T, Fujiwara M, Ali Y, Bhisitkul RB, Nakamura Y. Matsuda Y, et al. Among authors: bhisitkul rb. Mol Ther Nucleic Acids. 2019 Sep 6;17:819-828. doi: 10.1016/j.omtn.2019.07.018. Epub 2019 Aug 1. Mol Ther Nucleic Acids. 2019. PMID: 31454678 Free PMC article.

9

Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery.

Schlesinger EB, Bernards DA, Chen HH, Feindt J, Cao J, Dix D, Romano C, Bhisitkul RB, Desai TA. Schlesinger EB, et al. Among authors: bhisitkul rb. Bioeng Transl Med. 2018 Dec 3;4(1):152-163. doi: 10.1002/btm2.10121. eCollection 2019 Jan. Bioeng Transl Med. 2018. PMID: 30680326 Free PMC article.

10

Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device.

Samy KE, Cao Y, Kim J, Konichi da Silva NR, Phone A, Bloomer MM, Bhisitkul RB, Desai TA. Samy KE, et al. Among authors: bhisitkul rb. J Ocul Pharmacol Ther. 2019 Mar;35(2):124-131. doi: 10.1089/jop.2018.0096. Epub 2019 Jan 7. J Ocul Pharmacol Ther. 2019. PMID: 30615539 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

76 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year